
POV: Pharmacist
“Nulla feugiat ipsum arcu mi penatibus fringilla cursus ut mi. At eget condimentum pellentesque in amet.”
The Pharmacist's View >
Intro text here.Intro text here.Intro text here.Intro text here.Intro text here.Intro text here.Intro text here.Intro text here.Intro text here.Intro text here.Intro text here.Intro text here.Intro text here.Intro text here.Intro text here.Intro text here.Intro text here.Intro text here.
The Pharmacist's View >
The Nurse's View >
May 13, 2025
Recommendations on when to test and VTE management.
May 13, 2025
Evidence-based guidelines from the American Society of Hematology (ASH) intended to support decision making about thrombophilia testing.
May 13, 2025
Manuscript initiated by the Anticoagulation Forum providing clinical guidance for thrombophilia testing in five clinical situations.
May 13, 2025
Outline of the epidemiology and pathophysiology of cardiovascular disease and arterial and/or venous thrombosis in SLE, with/without APS.
May 13, 2025
Guidance based on literature and expert opinion provides recommendations for laboratory workers and clinicians on routine diagnostic assessment of...
May 13, 2025
Review summarizing the use of warfarin/VKA in patients with APS, along with venous and point-of-care INR monitoring.
May 13, 2025
This article highlights experience of a insitution with use of DOACs in patients with inherited antithrombin deficiency.
May 13, 2025
A single center, retrospective chart review of patients with APS on anticoagulation managed by ambulatory care clinical pharmacists.
May 13, 2025
While direct oral anticoagulants (DOACs) are frequently used to treat venous thromboembolism (VTE), the outcomes of patients with inherited...
Clinical FAQs provide practical guidance for healthcare professionals through offering evidence-based answers to common questions. These FAQs cover a wide range of topics to help healthcare professionals deliver high-quality patient care.
In patients on long-term oral anticoagulation with stable CAD, is antiplatelet therapy (APT) also indicated?
Read MoreIn patients prescribed warfarin for mechanical heart valve replacement (MHV), does an INR that is below the therapeutic range warrant LMWH therapy...
Read MoreTo measure yourselves against rigorous standards. Obtain a roadmap for operating at your highest level. If you succeed, you will obtain a 3-year...
Read MoreJoining the AC Forum is quick, easy, and free—simply complete our online registration form, and you'll instantly access all membership benefits, including newsletters and webinar invitations. By becoming a member, you join a community of excellence dedicated to improving patient care and advancing the management of thromboembolic diseases. Take the next step in your professional journey and register now to start enjoying the benefits of membership today.
"The knowledge I gained from AC Forum has been invaluable in tackling complex patient cases. While I had a solid foundation, the resources and insights provided by AC Forum helped me expand my expertise significantly."
"The AC Forum Resource Center is a goldmine of information. The resources are incredibly helpful and directly applicable to my daily practice. I frequently turn to the AC Forum website for guidance and support."
"The AC Forum webinars offer invaluable insights into treatment options and the decision-making process behind them. Each patient is unique, and weighing the benefits and risks can be challenging. "